Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bertoni

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumoursS Cresta, C Sessa, C V Catapano, et al.
Human Mutation|November 4, 2004
Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150CLeida B Rozeman, Luca Sangiorgi, Inge H Briaire-de Bruijn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2015
Histologic transformation in marginal zone lymphomas†A Conconi, S Franceschetti, K Aprile von Hohenstaufen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISHM Mian, A Rinaldi, A A Mensah, et al.
Placenta|July 12, 2008
Somatostatin as a regulator of first-trimester human trophoblast functionsC Biondi, M E Ferretti, L Lunghi, et al.
Tumori|April 25, 2000
Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor responseS Ferrari, M Mercuri, P Picci, et al.
Leukemia|May 19, 2009
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21D Rossi, S Rasi, S Franceschetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapyA J M Ferreri, R Dolcetti, M-Q Du, et al.
Cancer Detection and Prevention|April 2, 1999
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcomaP Ragazzini, G Gamberi, M S Benassi, et al.
Bullettino Delle Scienze Mediche|October 1, 1971
[Crohn's disease]A Franchini, E Belelli, F Bertoni, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumoursS Cresta, C Sessa, C V Catapano, et al.
Human Mutation|November 4, 2004
Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150CLeida B Rozeman, Luca Sangiorgi, Inge H Briaire-de Bruijn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2015
Histologic transformation in marginal zone lymphomas†A Conconi, S Franceschetti, K Aprile von Hohenstaufen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISHM Mian, A Rinaldi, A A Mensah, et al.
Placenta|July 12, 2008
Somatostatin as a regulator of first-trimester human trophoblast functionsC Biondi, M E Ferretti, L Lunghi, et al.
Tumori|April 25, 2000
Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor responseS Ferrari, M Mercuri, P Picci, et al.
Leukemia|May 19, 2009
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21D Rossi, S Rasi, S Franceschetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapyA J M Ferreri, R Dolcetti, M-Q Du, et al.
Cancer Detection and Prevention|April 2, 1999
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcomaP Ragazzini, G Gamberi, M S Benassi, et al.
Bullettino Delle Scienze Mediche|October 1, 1971
[Crohn's disease]A Franchini, E Belelli, F Bertoni, et al.
Pageof 35